Saturday, June 20, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Dividends

Nemetschek Proposes Significant Dividend Hike Following Record Revenue

Kennethcix by Kennethcix
March 16, 2026
in Dividends, Earnings, MDAX & SDAX, Tech & Software
0
Nemetschek Stock
0
SHARES
20
VIEWS
Share on FacebookShare on Twitter

The Nemetschek Group has announced a proposal to its shareholders for a substantial increase in its annual dividend. The software company is recommending a payout of €0.68 per share, marking a sharp 24% rise compared to the previous year’s distribution. This move comes on the heels of the firm surpassing the one-billion-euro revenue milestone for the first time.

Operational Strength Underpins Payout

This generous dividend proposal is grounded in a year of exceptional financial performance. For the 2025 fiscal year, Nemetschek achieved currency-adjusted group revenue of approximately €1.19 billion, representing robust growth of 22.6%. Profitability metrics were even stronger, with EBITDA expanding at a faster rate. The company’s EBITDA margin consequently improved, reaching 31.2%. Management’s decision to raise the shareholder return signals confidence in the sustainability of this earnings power.

Strategic Initiatives Fuel Performance

The company’s strategic focus has been a key driver of its solid results. A deliberate shift toward subscription and Software-as-a-Service (SaaS) revenue models, coupled with continued international expansion, has provided a stable foundation for growth. Looking forward, Nemetschek is channeling investments into areas like artificial intelligence, cloud-based solutions, and digital twin technology to maintain its momentum.

Should investors sell immediately? Or is it worth buying Nemetschek?

Financing this strategy is a newly arranged syndicated credit facility worth €500 million. This financing replaced previous bilateral credit lines and is reported to offer more favorable terms, providing the company with flexible capital for its initiatives.

Despite these operational successes, the company’s share price tells a different story. The stock, currently trading at €69.25, remains significantly depressed, showing a decline of roughly 40% over a one-year period and well below its prior-year levels. While the dividend increase alone is unlikely to fully reverse this market underperformance, it serves as a clear indicator that the underlying business remains healthy and cash-generative.

Ad

Nemetschek Stock: Buy or Sell?! New Nemetschek Analysis from June 20 delivers the answer:

The latest Nemetschek figures speak for themselves: Urgent action needed for Nemetschek investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 20.

Nemetschek: Buy or sell? Read more here...

Tags: Nemetschek
Kennethcix

Kennethcix

Related Posts

FALLBACK Stock
AI & Quantum Computing

When AI Interviews: Half of Germany’s Automated Candidate Chats Happen After Hours

June 20, 2026
IBM Stock
AI & Quantum Computing

IBM’s Bitter Pill: A Self-Published Study Triggers an 8% Share Price Slide

June 20, 2026
XPeng Stock
Asian Markets

XPeng’s Robotics Chief Exit Undermines Momentum as Robotaxi Production Ramps Up

June 20, 2026
Next Post
Onco-Innovations Stock

Onco-Innovations Secures Funding to Advance Cancer Drug Candidate

Glencore Stock

Glencore Navigates a Trio of Strategic Challenges

Newmont Stock

Navigating a Challenging Transition: Newmont's 2026 Outlook

Recommended

Silber Preis Stock

Silver’s Perfect Storm: Supply Crunch and Rate Cuts Fuel Rally

7 months ago
MSCI World ETF Stock

A Shift in Global Exposure: US Weighting Declines in Major World ETF

4 months ago

Analyst Reaffirms Buy Rating and 120 Price Target for Viking Therapeutics

2 years ago

Valeo Financial Advisors LLC Shows Confidence in Capital One Financial with Significant Increase in Holdings

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

XPeng’s Robotics Chief Exit Undermines Momentum as Robotaxi Production Ramps Up

UniCredit Nears Effective Control of Commerzbank as Tender Hits 12.5%

Cerebras Showcases Its 50-Times-Larger Chip in Singapore as First Earnings Test Approaches

Outlook Therapeutics Rallies as July Puts Two Crossroads in Sharp Focus

Netflix Stock: Short-Term Pain, Long-Term Gain as Ad Revenue and Free Cash Flow Take Center Stage

The Warsh Doctrine, Cheaper Oil, and Wall Street’s Token Experiment

Trending

FALLBACK Stock
AI & Quantum Computing

When AI Interviews: Half of Germany’s Automated Candidate Chats Happen After Hours

by Kennethcix
June 20, 2026
0

More than half of all AI-driven interactions with job applicants in Germany now take place outside standard...

IBM Stock

IBM’s Bitter Pill: A Self-Published Study Triggers an 8% Share Price Slide

June 20, 2026
St George Mining Stock

St George Mining Bets Big on Araxá with $60M Raise, Markets Deliver a 9% Blow

June 20, 2026
XPeng Stock

XPeng’s Robotics Chief Exit Undermines Momentum as Robotaxi Production Ramps Up

June 20, 2026
Unicredit Stock

UniCredit Nears Effective Control of Commerzbank as Tender Hits 12.5%

June 20, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • When AI Interviews: Half of Germany’s Automated Candidate Chats Happen After Hours
  • IBM’s Bitter Pill: A Self-Published Study Triggers an 8% Share Price Slide
  • St George Mining Bets Big on Araxá with $60M Raise, Markets Deliver a 9% Blow

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com